Effect of berberine on macrophage phenotypes of intestinal polyps using FAP animal models

Journal of Shanghai Jiaotong University (Medical Science)

Volumn 35, Issue 3, 2015, Pages 323-326

  Piao, Mei Yu ^a   Cao, Hai Long ^a   He, Na Na ^a   Xu, Meng Que ^a   Yan, Fang ^a   Zhou, Bing ^b   Wang, Bang Mao ^a  

^a TIANJIN MEDICAL UNIVERSITY   (China)

^b TIANJIN UNIVERSITY OF TRADITIONAL CHINESE MEDICINE   (China)

Author keywords

Apc(Min +) mouse; Berberine; Macrophage phenotypes; Tumor associated macrophage

Indexed keywords

BERBERINE; INDUCIBLE NITRIC OXIDE SYNTHASE; INTERLEUKIN 10; MANNOSE RECEPTOR; MESSENGER RNA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; FAMILIAL COLON POLYPOSIS; IMMUNOHISTOCHEMISTRY; INTESTINE POLYP; MACROPHAGE; MOUSE; NONHUMAN; PHENOTYPE; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION;

EID: 84928631439     PISSN: 16748115     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (13)

1. Caldwell GM, Jones CE, Ashley AM, et al. Wnt signaling in adenomas of familial adenomatous polyposis patients[J]. Br J Cancer, 2010, 103(6): 910-917.
2. Thirupurasunda CJ, Padmini R, Devaraj SN. Effect of Berberine on the antioxidant status, ultrastructural modifications and protein bound carbohydrates in azoxymethane-induced colon cancer in rats[J]. Chem Biol Interact, 2009, 177(3): 190-195.
3. Heusinkveld M, van der Burg SH. Identification and manipulation of tumor associated macrophages in human cancers[J]. J Transl Med, 2011, 9: 216.
4. McClellan JL, Davis JM, Steiner JL, et al. Linking tumor associated macrophages, inflammation, and intestinal tumor genesis: role of MCP-1[J]. Am J Physiol Gastrointest Liver Physiol, 2012, 303(10): G1087-G1095.
5. Shimizu H, Tanaka S, Mori M. Adrenalectomy enhance the susceptibility of pancreatic islets to interlukin-1 beta: immunohistochemical study[J]. Endocrinol Jpn, 1992, 39(5): 485-490.
6. Half E, Arber N. Colon cancer: preventive agents and the present status of chemoprevention[J]. Expert Opin Pharmacother, 2009, 10(2): 211-219.
7. Lawrence T. Inflammation and cancer: a failure of resolution[J]. Trends Pharmacol Sci, 2007, 28(4): 162-165.
8. Qian BZ, Pollard JW. Macrophage diversity enhances tumor progression and metastasis[J]. Cell, 2010, 141(1): 39-51.
9. Zhang B, Yang G, Zhang Y, et al. M2 polarized tumor associated macrophages are associated with poor prognoses resulting from accelerated lymphangiogenesis in lung adenocarcinoma[J]. Clinics, 2011, 66(11): 1879-1886.
10. Mosser DM, Edwords JP. Exploring the full spectrum of macrophage activation[J]. Nat Rev Immunol, 2008, 8(12): 958-969.
11. Heusinkveld M, de Vos van Steenwijk PJ, Goedemans R, et al. M2 macrophages induced by prostaglandin E2 and IL-6 from cervical carcinoma are switched to activated M1 macrophages by CD4+ Th1 cells[J]. Immunol, 2011, 187(3): 1157-1165.
12. Qian BZ, Pollard JW. Macrophage diversity enhances tumor progression and metastasis[J]. Cell, 2010, 141(1): 39-51.
13. Dijkgraaf EM, Heusinkveld M, Tummers B, et al. Chemotherapy alters monocyte differentiation to favor generation of cancer-supporting M2 macrophages in the tumor microenvironment[J]. Cancer Res, 2013, 73(8): 2480-2492.